Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06828601Phase 4Not yet recruiting
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in pain, sponsored by University of Washington. Planned start Apr 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06828601.